𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia

✍ Scribed by Charles L. Sawyers; David W. Golde; Shirley Quan; Stephen D. Nimer

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
421 KB
Volume
69
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Eosinophilia associated with adult t-cel
Eosinophilia associated with adult t-cell leukemia: Role of interleukin 5 and granulocyte-macrophage colony-stimulating factor
✍ Ogata, Masao; Ogata, Yuko; Kohno, Kazuhiro; Uno, Noritaka; Ohno, Eiji; Ohtsuka, πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 29 KB πŸ‘ 2 views

To clarify the mechanism of eosinophilia in adult T-cell leukemia (ATL), we studied three ATL patients having marked eosinophilia. Eosinophil-predominant colony-stimulating activity was detected in the serum of one patient and in the conditioned media (CM) from cultured ATL cells from two patients.

Combination chemotherapy with granulocyt
Combination chemotherapy with granulocyte-macrophage–colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma
✍ Susan Partyka; Pamela Dumas; Jaffer Ajani πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 59 KB πŸ‘ 2 views

## BACKGROUND. A combination of etoposide, 5-fluorouracil, and folinic acid (ELF) remains popular for the treatment of patients with gastric carcinoma and has been reported to result in a response rate of up to 40% with good patient tolerance. The authors elected to add granulocyte-macrophage-colo

Eosinophilia resulting from administrati
Eosinophilia resulting from administration of recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in a patient with T-Ξ³ lymphoproliferative disease
✍ R. Gonzales-Chambers; Dr. C. Rosenfeld; A. Winkelstein; L. Dameshek πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 1 views

A therapeutic trial of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was attempted in a patient with neutropenia and frequent infections secondary to T-y lymphoproliferative disease (T-y LPD). During the 14 days of subcutaneous rhGM-CSF (500 kg/m2/day), the absolute e